A pragmatic adaptation of the RANO clinical risk score for IDH-Wildtype glioblastoma in the absence of MGMT promoter methylation testing.
- DOI
- 10.1080/14796694.2026.2713370
- Published
- 2026 Aug
- Container
- Future oncology (London, England)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/14796694.2026.2713370,
title = {A pragmatic adaptation of the RANO clinical risk score for IDH-Wildtype glioblastoma in the absence of MGMT promoter methylation testing.},
author = {Eroğlu İ and Koçoğlu SS and Merovci E and Savaş G and Gürler F and Sutcuoglu O and Coskun U and Uner A and Ucar M and Karaarslan B and Özet A and Özdemir N and Yazıcı O},
year = {2026},
journal = {Future oncology (London, England)},
doi = {10.1080/14796694.2026.2713370},
url = {https://doi.org/10.1080/14796694.2026.2713370}
}RIS
TY - JOUR TI - A pragmatic adaptation of the RANO clinical risk score for IDH-Wildtype glioblastoma in the absence of MGMT promoter methylation testing. AU - Eroğlu İ AU - Koçoğlu SS AU - Merovci E AU - Savaş G AU - Gürler F AU - Sutcuoglu O AU - Coskun U AU - Uner A AU - Ucar M AU - Karaarslan B AU - Özet A AU - Özdemir N AU - Yazıcı O PY - 2026 JO - Future oncology (London, England) DO - 10.1080/14796694.2026.2713370 UR - https://doi.org/10.1080/14796694.2026.2713370 ER -
APA
İ, E., SS, K., E, M., G, S., F, G., O, S., U, C., A, U., M, U., B, K., A, Ö., N, Ö., & O, Y. (2026). A pragmatic adaptation of the RANO clinical risk score for IDH-Wildtype glioblastoma in the absence of MGMT promoter methylation testing.. Future oncology (London, England). https://doi.org/10.1080/14796694.2026.2713370
Source records
- pubmed · retrieved 2026-09-26T22:14:04.838Z